Indications and uses
Controls the symptoms of diarrhea, including Travelers diarrhea.
Controls the symptoms of diarrhea, including Travelers diarrhea.
do not use more than directed drink plenty of clear fluids to help prevent dehydration caused by diarrhea Adults and children (12 years and older): Take 2 caplets after the first loose stool followed by 1 caplet after each subsequent loose stool but no more than 4 caplets in 24 hours. Children under 12 years: Do not give to children under 12 years of age.
Drug Facts
Loperamide Hydrochloride 2mg
Antidiarrheal
Controls the symptoms of diarrhea, including Travelers diarrhea.
Allergy alert:Do not use if you have ever had a rash or other allergic reaction to Loperamide HCl
If you are pregnant or breast feeding, ask a health professional before use.
Keep this and all drugs out of the reach of children. In case of accidental overdose, contact a physician or Poison Control Center right away.
Adults and children (12 years and older):Take 2 caplets after the first loose stool followed by 1 caplet after each subsequent loose stool but no more than 4 caplets in 24 hours.
Children under 12 years:Do not give to children under 12 years of age.
anhydrous lactose, croscarmellose sodium, crospovidone, D&C Yellow # 10, FD&C Blue # 1, hydrogenated vegetable oil, magnesium stearate, powdered cellulose, pregelatinized starch
| Class | Version | Type | Effective |
|---|---|---|---|
| LOPERAMIDE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 10f838ef-a72b-645d-80f8-e2255205c3b1 | Product name | 6 | 20240805 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85766-120-01 | MEDIQUE Diamode | 1 in 1 PACKET | TABLET | 1 | 2 | |
| 85766-120-06 | MEDIQUE Diamode | 6 in 1 BOX, UNIT-DOSE | TABLET | 6 | 2 | |
| 85766-120-06 | MEDIQUE Diamode | 1 in 1 PACKET | TABLET | 1 | 2 | |
| 85766-120-24 | MEDIQUE Diamode | 24 in 1 BOX, UNIT-DOSE | TABLET | 24 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 47682-200-33 | EA - Each | 47682-200 | f07bc0d3-2ced-4052-ba14-126376ba97df | 1 | 2012-07-24 |
| 47682-200-50 | EA - Each | 47682-200 | 1792fba4-32e7-461b-9844-385042675db5 | 1 | 2012-07-24 |
| 47682-200-64 | EA - Each | 47682-200 | 94aca123-bb93-43e6-bf00-3c3df07db82a | 1 | 2023-08-08 |
| 47682-200-69 | EA - Each | 47682-200 | 80247ac0-4431-4ac1-893d-7b7a9a0347e9 | 1 | 2012-07-24 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85766-120 | 85766-120-06, 85766-120-01, 85766-120-24 |
| 47682-200 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS LACTOSE | 3SY5LH9PMK | IACT |
| CROSPOVIDONE | 2S7830E561 | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| POWDERED CELLULOSE | SMD1X3XO9M | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| LOPERAMIDE HYDROCHLORIDE | 77TI35393C | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2025-12-11 | monthly-update | 2026-06-03 17:46:23 |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074091-001 | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074091-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | TABLET / ORAL | 1992-12-10 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MEDIQUE Diamode | LOPERAMIDE HYDROCHLORIDE | Sportpharm LLC | ac674e5a-94df-4a35-9854-4e66cc17e509 | 2026-04-24 | Warnings | 85766-120-24 85766-120-06 85766-120-01 85766-120 85766012001 85766012006 85766012024 503225c0-98ca-4e90-e063-6394a90af07d ac674e5a-94df-4a35-9854-4e66cc17e509 |
| Private Label Distributor | LOPERAMIDE HCL 2 MG | Unifirst First Aid Corporation | 069e7979-a223-4819-b6cf-ea2731bf156b | 2025-12-01 | Warnings | 47682-200 |
Adverse event summaries are temporarily unavailable. Other product information remains available.